TheEdgeResearch
Home / Stocks / VREOF

Vireo Growth Inc. (VREOF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$5.23 ▼ -2.24%
Market Cap
$302.7M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.07
52-Wk Range
4.905-21.75
CEO
John Mazarakis
Country
US
Currency
USD

Vireo Growth Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Minneapolis, MN, US. The stock last traded at $5.23, down 2.24% on the session, giving a market capitalisation of $302.7M. On trailing twelve-month figures it carries a trailing P/E of -3.20, a net margin of -9.6%. Its beta of 0.07 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.20
Price / Sales
0.45
Price / Book
0.52
EV / EBITDA
8.64
Gross margin
46.6%
Operating margin
3.7%
Net margin
-9.6%
Return on equity
—
Debt / equity
1.04
Current ratio
2.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
612
IPO date
2019-03-18
Headquarters
Minneapolis, MN, US
About Vireo Growth Inc.

Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024. Vireo Growth Inc. was incorporated in 2004 and is headquartered in Minneapolis, Minnesota.

Comparable companies

Vireo Growth Inc. is most often compared with the following Healthcare names:

AAWHCRLBFCURLFFIORFGLASITHUFMRMDPLNHVEXTFVRNO
More research on VREOF
VREOF technical analysis VREOF TheEdge Score Compare against peers
Open full interactive analysis & DCF →